The cores regulation of paraffin-chitosan phase change microcapsules for constant temperature building.

J Colloid Interface Sci

Suzhou Techinno New Materials Technologies Co., Ltd., Jiangsu 215500, China. Electronic address:

Published: October 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Phase change materials (PCMs) can store and release latent heat under the designed phased change temperature and have received substantial interest for energy conservation and thermal control purposes. The use of PCMs in the construction of constant temperature buildings can improve the comfortable environment and save more energy. However, the leakage of PCMs during phase change process limits the application of PCMs. In this paper, a series of PCMs microcapsules with controllable core numbers is synthesized with paraffin (37 ℃) as the core and cross-linked chitosan as the wall. The single-core phase-change microcapsules (S-PCM) and multicore phase-change microcapsules (M-PCM) were prepared by adjusting the preparation condition. The latent heat of S-PCM and M-PCM are 61.4 mJ mg and 50.1 mJ mg, respectively. The S-PCM and M-PCM display good stability without paraffin leakage. In addition, the composite blocks of gypsum and S-PCM (GSCM) and M-PCM (GMCM) were prepared and the thermoregulatory effection was investigated, where the surface temperature of GSCM was 5-10 ℃ lower than that of pure gypsum block. PCMs may also have broad application space in electronics, cold chain, and other industries.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcis.2024.06.006DOI Listing

Publication Analysis

Top Keywords

phase change
12
constant temperature
8
latent heat
8
phase-change microcapsules
8
s-pcm m-pcm
8
pcms
6
cores regulation
4
regulation paraffin-chitosan
4
paraffin-chitosan phase
4
change
4

Similar Publications

Background: Various media are used to enhance public understanding about diseases. While mobile health apps are widely used, there is little proof for using such apps to raise awareness of skin diseases.

Objective: We intend to develop an app, called DEDIKASI-app, to raise awareness of skin diseases, including leprosy.

View Article and Find Full Text PDF

It is helpful for diagnostic purposes to improve our current knowledge of gut development and serum biochemistry in young piglets. This study investigated serum biochemistry, and gut site-specific patterns of short-chain fatty acids (SCFA) and expression of genes related to barrier function, innate immune response, antioxidative status and sensing of fatty and bile acids in suckling and newly weaned piglets. The experiment consisted of two replicate batches with 10 litters each.

View Article and Find Full Text PDF

Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.

Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.

Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).

View Article and Find Full Text PDF

In pig production, weaning is a critical period where piglets face several environmental stressors. This transition leads to a significant growth reduction and can result in digestive disorders, including diarrhea. To formulate a feed that meets zinc (Zn) and copper (Cu) requirements during the weaning period while minimizing their release into the environment, it became evident that a more bioavailable micro-mineral supplement is necessary.

View Article and Find Full Text PDF

Introduction: No head-to-head studies comparing the efficacy of avalglucosidase alfa (AVA) with cipaglucosidase alfa + miglustat (Cipa+mig) have been conducted in patients with late-onset Pompe disease (LOPD). Two indirect treatment comparisons (ITCs) were conducted to estimate the effects of AVA versus Cipa+mig.

Methods: ITCs were conducted using simulated treatment comparisons (STCs), adjusting for differences in prognostic factors and treatment effect modifiers.

View Article and Find Full Text PDF